Medical Device and Wound Care News and Analysis Blog

Elective Procedure Volumes Improving: Q322 Total Joints Market Trends

Written by Lisa Mahan | 12/8/22 2:30 PM

Even stronger foreign exchange headwinds inhibit revenue growth from steadily improving elective procedural trends 

Procedural volumes appear to be steadily improving overall as the COVID pandemic comes close to the end of its third year. Despite the return of procedures, foreign currency headwinds in Q322 strengthened, negatively impacting reported revenue growth for most companies in markets outside the US. Global companies with a strong international presence were most adversely affected.

Among the many topics covered in detail in our comprehensive Q322 Total Joints Market Recap* are:

  • Complete Q322 Total Joints Market Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News, Revenues, Data, Charts and Shares
  • Improving Procedural Volumes Leaning into Strengthening Foreign Exchange Headwinds
  • Hips: Muscle-Sparing Solutions and New Products Driving Growth
  • Knees: Assistive Tech Driving Implant Pull-Through
  • Q322 Regulatory Highlights

Stryker reported experiencing improving procedural volumes but with slower growth in the APAC region. The Company anticipates that strong growth in its Hip and Knee businesses will continue into 2023 and possibly 2024. However, Stryker is also anticipating ...

Read the entire Q322 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

SmartTRAK is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click here.